Table 6.
Analysis of Cross-Validated performance metrics for all Predictors.
| Predictor | Accuracy (95% CI) | Kappa (95% CI) | AUC |
|---|---|---|---|
| LMR | 0.699 (0.646–0.751) | 0.308 (0.189–0.427) | 0.731 |
| ALB/GLB | 0.695 (0.642–0.748) | 0.301 (0.183–0.419) | 0.724 |
| Serum albumin | 0.693 (0.639–0.747) | 0.295 (0.182–0.408) | 0.715 |
| ECOG PS | 0.685 (0.631–0.739) | 0.282 (0.161–0.403) | 0.708 |
| Age | 0.682 (0.627–0.737) | 0.275 (0.147–0.403) | 0.701 |
| HRR | 0.691 (0.640–0.742) | 0.293 (0.181–0.405) | 0.712 |
| Clinical stage | 0.672 (0.621–0.723) | 0.259 (0.138–0.380) | 0.694 |
| Differentiation | 0.664 (0.608–0.720) | 0.236 (0.109–0.363) | 0.687 |
Note: RFE Selected Variables: Clinical Stage (Stage I)、Differentiation Grade (Poor differentiation)、ECOG Performance Status (0–1)、Serum Albumin (g/L)、Lymphocyte-to-Monocyte Ratio (LMR)、High-Risk Ratio (HRR)、Albumin-to-Globulin Ratio (ALB/GLB)、Age (years).